Ken Griffin (Citadel Advisors) exit United Therapeutics Corporation
Ken Griffin (Citadel Advisors) exit $-148.9M of disclosed value in United Therapeutics Corporation.
Signal
Investor Move
Action
Exit
Capital
$-148.9M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.